Problem:
I read an interesting article in "The New Yorker" magazine, "The Treatment", by Malcolm Gladwell.
In it he talks about two approaches to finding a working cancer drug: "rational design" and "mass screening".
The first is the norm and involves starting with the disease and working backward to find or create a drug. The second starts with a drug candidate then look for a disease it might combat.
Two radically different approaches and I am interested if you can see how the ideas in the article might apply to question of 'how higher quality can lead to lower costs' or a discussion along that line.
The article can be found at:
https://www.gladwell.com/2010/2010_05_17_a_treatment.html